Search

Your search keyword '"Garvey, Lena H' showing total 3 results
Start Over Author "Garvey, Lena H
3 results on '"Garvey, Lena H'

1. Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.

Author

Traidl‐Hoffmann, Claudia, Afghani, Jamie, Akdis, Cezmi A., Akdis, Mübecel, Aydin, Handan, Bärenfaller, Katja, Behrendt, Heidrun, Bieber, Thomas, Bigliardi, Paul, Bigliardi‐Qi, Mei, Bonefeld, Charlotte Menné, Bösch, Stefanie, Brüggen, Marie Charlotte, Diemert, Sebastian, Duchna, Hans‐Werner, Fähndrich, Martina, Fehr, Danielle, Fellmann, Marc, Frei, Remo, and Garvey, Lena H.

Subjects
PATIENT advocacy, ATOPIC dermatitis, TARGETED advertising, DISEASE management, STAKEHOLDER analysis
Abstract

The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient‐centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

2. Navigating the evolving landscape of atopic dermatitis:Challenges and future opportunities: The 4th Davos declaration

Author

Traidl-Hoffmann, Claudia, Afghani, Jamie, Akdis, Cezmi, Akdis, Mübecel, Aydin, Handan, Bärenfaller, Katja, Behrendt, Heidrun, Bieber, Thomas, Bigliardi, Paul, Bigliardi-Qi, Mei, Bonefeld, Charlotte Menné, Bösch, Stefanie, Brüggen, Marie Charlotte, Diemert, Sebastian, Duchna, Hans Werner, Fähndrich, Martina, Fehr, Danielle, Fellmann, Marc, Frei, Remo, Garvey, Lena H., Gharbo, Raschid, Gökkaya, Mehmet, Grando, Karin, Guillet, Carole, Guler, Erman, Gutermuth, Jan, Herrmann, Nadine, Hijnen, Dirk Jan, Hülpüsch, Claudia, Irvine, Alan D., Jensen-Jarolim, Erika, Kong, Heidi H., Koren, Hillel, Lang, Claudia C.V., Lauener, Roger, Maintz, Laura, Mantel, Pierre Yves, Maverakis, Emanuel, Möhrenschlager, Matthias, Müller, Svenja, Nadeau, Kari, Neumann, Avidan U., O'Mahony, Liam, Rabenja, Fahafahantsoa Rapelanoro, Renz, Harald, Rhyner, Claudio, Rietschel, Ernst, Ring, Johannes, Roduit, Caroline, Sasaki, Mari, Schenk, Mirjam, Schröder, Jens, Simon, Dagmar, Simon, Hans Uwe, Sokolowska, Milena, Ständer, Sonja, Steinhoff, Martin, Piccirillo, Doris Straub, Taïeb, Alain, Takaoka, Roberto, Tapparo, Martin, Teixeira, Henrique, Thyssen, Jacob Pontoppidan, Traidl, Stephan, Uhlmann, Miriam, van de Veen, Willem, van Hage, Marianne, Virchow, Christian, Wollenberg, Andreas, Yasutaka, Mitamura, Zink, Alexander, Schmid-Grendelmeier, Peter, Traidl-Hoffmann, Claudia, Afghani, Jamie, Akdis, Cezmi, Akdis, Mübecel, Aydin, Handan, Bärenfaller, Katja, Behrendt, Heidrun, Bieber, Thomas, Bigliardi, Paul, Bigliardi-Qi, Mei, Bonefeld, Charlotte Menné, Bösch, Stefanie, Brüggen, Marie Charlotte, Diemert, Sebastian, Duchna, Hans Werner, Fähndrich, Martina, Fehr, Danielle, Fellmann, Marc, Frei, Remo, Garvey, Lena H., Gharbo, Raschid, Gökkaya, Mehmet, Grando, Karin, Guillet, Carole, Guler, Erman, Gutermuth, Jan, Herrmann, Nadine, Hijnen, Dirk Jan, Hülpüsch, Claudia, Irvine, Alan D., Jensen-Jarolim, Erika, Kong, Heidi H., Koren, Hillel, Lang, Claudia C.V., Lauener, Roger, Maintz, Laura, Mantel, Pierre Yves, Maverakis, Emanuel, Möhrenschlager, Matthias, Müller, Svenja, Nadeau, Kari, Neumann, Avidan U., O'Mahony, Liam, Rabenja, Fahafahantsoa Rapelanoro, Renz, Harald, Rhyner, Claudio, Rietschel, Ernst, Ring, Johannes, Roduit, Caroline, Sasaki, Mari, Schenk, Mirjam, Schröder, Jens, Simon, Dagmar, Simon, Hans Uwe, Sokolowska, Milena, Ständer, Sonja, Steinhoff, Martin, Piccirillo, Doris Straub, Taïeb, Alain, Takaoka, Roberto, Tapparo, Martin, Teixeira, Henrique, Thyssen, Jacob Pontoppidan, Traidl, Stephan, Uhlmann, Miriam, van de Veen, Willem, van Hage, Marianne, Virchow, Christian, Wollenberg, Andreas, Yasutaka, Mitamura, Zink, Alexander, and Schmid-Grendelmeier, Peter

Abstract

The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient-centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.

Published
2024

3. Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration

Author

Traidl‐Hoffmann, Claudia; https://orcid.org/0000-0001-5085-5179, Afghani, Jamie, Akdis, Cezmi A; https://orcid.org/0000-0001-8020-019X, Akdis, Mübecel; https://orcid.org/0000-0003-0554-9943, Aydin, Handan, Bärenfaller, Katja; https://orcid.org/0000-0002-1904-9440, Behrendt, Heidrun, Bieber, Thomas; https://orcid.org/0000-0002-8800-3817, Bigliardi, Paul, Bigliardi‐Qi, Mei, Bonefeld, Charlotte Menné; https://orcid.org/0000-0002-0523-6229, Bösch, Stefanie, Brüggen, Marie Charlotte; https://orcid.org/0000-0002-8607-6254, Diemert, Sebastian, Duchna, Hans‐Werner, Fähndrich, Martina, Fehr, Danielle; https://orcid.org/0000-0001-6361-3662, Fellmann, Marc; https://orcid.org/0000-0003-0064-698X, Frei, Remo, Garvey, Lena H; https://orcid.org/0000-0002-7777-4501, Gharbo, Raschid, Gökkaya, Mehmet, Grando, Karin, Guillet, Carole; https://orcid.org/0000-0003-3809-0526, Guler, Erman, Gutermuth, Jan; https://orcid.org/0000-0002-5805-3784, Lang, Claudia C V; https://orcid.org/0000-0003-0469-7661, van de Veen, Willem; https://orcid.org/0000-0001-9951-6688, Yasutaka, Mitamura, Schmid-Grendelmeier, Peter; https://orcid.org/0000-0003-3215-3370, et al, Traidl‐Hoffmann, Claudia; https://orcid.org/0000-0001-5085-5179, Afghani, Jamie, Akdis, Cezmi A; https://orcid.org/0000-0001-8020-019X, Akdis, Mübecel; https://orcid.org/0000-0003-0554-9943, Aydin, Handan, Bärenfaller, Katja; https://orcid.org/0000-0002-1904-9440, Behrendt, Heidrun, Bieber, Thomas; https://orcid.org/0000-0002-8800-3817, Bigliardi, Paul, Bigliardi‐Qi, Mei, Bonefeld, Charlotte Menné; https://orcid.org/0000-0002-0523-6229, Bösch, Stefanie, Brüggen, Marie Charlotte; https://orcid.org/0000-0002-8607-6254, Diemert, Sebastian, Duchna, Hans‐Werner, Fähndrich, Martina, Fehr, Danielle; https://orcid.org/0000-0001-6361-3662, Fellmann, Marc; https://orcid.org/0000-0003-0064-698X, Frei, Remo, Garvey, Lena H; https://orcid.org/0000-0002-7777-4501, Gharbo, Raschid, Gökkaya, Mehmet, Grando, Karin, Guillet, Carole; https://orcid.org/0000-0003-3809-0526, Guler, Erman, Gutermuth, Jan; https://orcid.org/0000-0002-5805-3784, Lang, Claudia C V; https://orcid.org/0000-0003-0469-7661, van de Veen, Willem; https://orcid.org/0000-0001-9951-6688, Yasutaka, Mitamura, Schmid-Grendelmeier, Peter; https://orcid.org/0000-0003-3215-3370, and et al

Abstract

The 4th Davos Declaration was developed during the Global Allergy Forum in Davos which aimed to elevate the care of patients with atopic dermatitis (AD) by uniting experts and stakeholders. The forum addressed the high prevalence of AD, with a strategic focus on advancing research, treatment, and management to meet the evolving challenges in the field. This multidisciplinary forum brought together top leaders from research, clinical practice, policy, and patient advocacy to discuss the critical aspects of AD, including neuroimmunology, environmental factors, comorbidities, and breakthroughs in prevention, diagnosis, and treatment. The discussions were geared towards fostering a collaborative approach to integrate these advancements into practical, patient‐centric care. The forum underlined the mounting burden of AD, attributing it to significant environmental and lifestyle changes. It acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in translating these innovations into clinical practice. Emphasis was placed on the need for enhanced awareness, education, and stakeholder engagement to address this gap effectively and to consider environmental and lifestyle factors in a comprehensive disease management strategy. The 4th Davos Declaration marks a significant milestone in the journey to improve care for people with AD. By promoting a holistic approach that combines research, education, and clinical application, the Forum sets a roadmap for stakeholders to collaborate to improve patient outcomes in AD, reflecting a commitment to adapt and respond to the dynamic challenges of AD in a changing world.

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results